ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 487

$643K Total Retail Price of All Prescriptions

Rank: 16 out of 487

381 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 381 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 381 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,282 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
HYDROCODONE-ACETAMINOPHEN 336 231 S3 1 3
ATORVASTATIN CALCIUM 314 290 2 18
LEVOTHYROXINE SODIUM 312 231 3 1
SIMVASTATIN 299 256 4 4
OMEPRAZOLE 243 198 5 2
FUROSEMIDE 225 197 6 7
POTASSIUM CHLORIDE 180 172 7 10
AMLODIPINE BESYLATE 169 157 8 6
METFORMIN HCL ER 165 142 9 31
CITALOPRAM HBR 160 144 10 12
ZOLPIDEM TARTRATE 157 135 11 14
LOSARTAN POTASSIUM 147 141 12 16
LISINOPRIL 142 125 13 5
GABAPENTIN 142 105 13 13
TRAZODONE HCL 127 103 15 22
WARFARIN SODIUM 121 121 16 11
METFORMIN HCL 108 85 17 8
SERTRALINE HCL 106 87 18 21
HYDROCHLOROTHIAZIDE 94 89 19 9
ALENDRONATE SODIUM 87 86 20 27
PANTOPRAZOLE SODIUM 83 58 21 62
DIGOXIN 79 78 22 47
ADVAIR DISKUS 76 66 23 46
OXYCONTIN 75 27 S2 24 145
METOPROLOL TARTRATE 72 68 25 17
ALLOPURINOL 71 65 26 29
ACTOS 69 51 27 88
ZETIA 68 55 28 104
MELOXICAM 66 51 29 26
FLUOXETINE HCL 65 41 30 28
GLIPIZIDE ER 65 64 30 95
PREMARIN 64 62 R 32 89
CELEBREX 63 59 33 103
AMITRIPTYLINE HCL 62 57 R 34 45
TRIAMTERENE-HCTZ 61 61 35 49
OXYCODONE HCL 60 24 S2 36 57
METOPROLOL SUCCINATE 58 58 37 15
FENOFIBRATE 56 44 38 61
TAMSULOSIN HCL 52 46 39 25
LOSARTAN-HYDROCHLOROTHIAZIDE 52 44 39 52
SYNTHROID 51 51 41 87
TRAMADOL HCL 51 21 41 19
CARVEDILOL 50 43 43 32
BUPROPION XL 50 49 43 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.